RU2014102948A - Вакцинная композиция для мукозального введения - Google Patents
Вакцинная композиция для мукозального введения Download PDFInfo
- Publication number
- RU2014102948A RU2014102948A RU2014102948/15A RU2014102948A RU2014102948A RU 2014102948 A RU2014102948 A RU 2014102948A RU 2014102948/15 A RU2014102948/15 A RU 2014102948/15A RU 2014102948 A RU2014102948 A RU 2014102948A RU 2014102948 A RU2014102948 A RU 2014102948A
- Authority
- RU
- Russia
- Prior art keywords
- agonist
- receptor
- inhibitor
- receptor agonist
- antagonist
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract 10
- 239000000556 agonist Substances 0.000 claims abstract 28
- 239000003112 inhibitor Substances 0.000 claims abstract 11
- 229940044601 receptor agonist Drugs 0.000 claims abstract 9
- 239000000018 receptor agonist Substances 0.000 claims abstract 9
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 claims abstract 8
- 239000012190 activator Substances 0.000 claims abstract 6
- 230000007969 cellular immunity Effects 0.000 claims abstract 5
- 230000006698 induction Effects 0.000 claims abstract 5
- AHOKKYCUWBLDST-QYULHYBRSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=CC=C1 AHOKKYCUWBLDST-QYULHYBRSA-N 0.000 claims abstract 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims abstract 4
- 101800000324 Immunoglobulin A1 protease translocator Proteins 0.000 claims abstract 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims abstract 4
- 201000011510 cancer Diseases 0.000 claims abstract 4
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 claims abstract 3
- 229940098778 Dopamine receptor agonist Drugs 0.000 claims abstract 3
- 229940121891 Dopamine receptor antagonist Drugs 0.000 claims abstract 3
- 229940123322 Histamine receptor agonist Drugs 0.000 claims abstract 3
- 229940122236 Histamine receptor antagonist Drugs 0.000 claims abstract 3
- 229940121723 Melatonin receptor agonist Drugs 0.000 claims abstract 3
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 claims abstract 3
- 102100037600 P2Y purinoceptor 1 Human genes 0.000 claims abstract 3
- 229940126033 PPAR agonist Drugs 0.000 claims abstract 3
- 229940118169 Prostaglandin receptor agonist Drugs 0.000 claims abstract 3
- 108010085249 Purinergic P2 Receptors Proteins 0.000 claims abstract 3
- 229940121846 Sphingosine 1-phosphate receptor agonist Drugs 0.000 claims abstract 3
- 102000004136 Vasopressin Receptors Human genes 0.000 claims abstract 3
- 108090000643 Vasopressin Receptors Proteins 0.000 claims abstract 3
- 239000002253 acid Substances 0.000 claims abstract 3
- 239000000739 antihistaminic agent Substances 0.000 claims abstract 3
- 239000003420 antiserotonin agent Substances 0.000 claims abstract 3
- 229940121376 cannabinoid receptor agonist Drugs 0.000 claims abstract 3
- 239000003537 cannabinoid receptor agonist Substances 0.000 claims abstract 3
- 125000004122 cyclic group Chemical group 0.000 claims abstract 3
- 239000003210 dopamine receptor blocking agent Substances 0.000 claims abstract 3
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims abstract 3
- 229940079593 drug Drugs 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 3
- 239000003453 histamine agonist Substances 0.000 claims abstract 3
- 230000002519 immonomodulatory effect Effects 0.000 claims abstract 3
- 239000003199 leukotriene receptor blocking agent Substances 0.000 claims abstract 3
- 239000003789 leukotriene receptor stimulating agent Substances 0.000 claims abstract 3
- 239000003446 ligand Substances 0.000 claims abstract 3
- 239000003514 metabotropic receptor agonist Substances 0.000 claims abstract 3
- 239000003149 muscarinic antagonist Substances 0.000 claims abstract 3
- 239000002307 peroxisome proliferator activated receptor agonist Substances 0.000 claims abstract 3
- 239000002522 prostaglandin receptor stimulating agent Substances 0.000 claims abstract 3
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 claims abstract 3
- 229940121356 serotonin receptor antagonist Drugs 0.000 claims abstract 3
- 239000002536 vasopressin receptor antagonist Substances 0.000 claims abstract 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract 2
- 229940121743 Muscarinic receptor agonist Drugs 0.000 claims abstract 2
- 108010014865 PLIalpha Proteins 0.000 claims abstract 2
- 229940123898 Phospholipase A2 inhibitor Drugs 0.000 claims abstract 2
- 229940122144 Prostaglandin receptor antagonist Drugs 0.000 claims abstract 2
- 108050001286 Somatostatin Receptor Proteins 0.000 claims abstract 2
- 102000011096 Somatostatin receptor Human genes 0.000 claims abstract 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims abstract 2
- 229930195712 glutamate Natural products 0.000 claims abstract 2
- 229940049906 glutamate Drugs 0.000 claims abstract 2
- 239000000472 muscarinic agonist Substances 0.000 claims abstract 2
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract 2
- 239000003358 phospholipase A2 inhibitor Substances 0.000 claims abstract 2
- 239000002089 prostaglandin antagonist Substances 0.000 claims abstract 2
- 229940044551 receptor antagonist Drugs 0.000 claims abstract 2
- 239000002464 receptor antagonist Substances 0.000 claims abstract 2
- 230000023750 transforming growth factor beta production Effects 0.000 claims abstract 2
- 229940124154 Phospholipase inhibitor Drugs 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 239000003428 phospholipase inhibitor Substances 0.000 claims 2
- 230000023441 thymic stromal lymphopoietin production Effects 0.000 claims 2
- NPILLHMQNMXXTL-UHFFFAOYSA-N 4,4'-dimethylaminorex Chemical compound CC1N=C(N)OC1C1=CC=C(C)C=C1 NPILLHMQNMXXTL-UHFFFAOYSA-N 0.000 claims 1
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 claims 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 claims 1
- 229940122658 Adenylate cyclase inhibitor Drugs 0.000 claims 1
- 102000008873 Angiotensin II receptor Human genes 0.000 claims 1
- 108050000824 Angiotensin II receptor Proteins 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 229940121954 Opioid receptor agonist Drugs 0.000 claims 1
- 102000015433 Prostaglandin Receptors Human genes 0.000 claims 1
- 108010050183 Prostaglandin Receptors Proteins 0.000 claims 1
- 229940123051 Somatostatin receptor agonist Drugs 0.000 claims 1
- 229940117028 Thrombin receptor agonist Drugs 0.000 claims 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000003402 opiate agonist Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000952 serotonin receptor agonist Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000003856 thrombin receptor antagonist Substances 0.000 claims 1
- OXHYRVSBKWIFES-WWSDOYNLSA-N trap-14 peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=CC=C1 OXHYRVSBKWIFES-WWSDOYNLSA-N 0.000 claims 1
- 229940123561 Fatty acid inhibitor Drugs 0.000 abstract 1
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 abstract 1
- WUKZPHOXUVCQOR-UHFFFAOYSA-N N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide Chemical compound C1N(CC2)CCC2C1NC(=O)C1=CC(Cl)=CC2=C1OCC(=O)N2C WUKZPHOXUVCQOR-UHFFFAOYSA-N 0.000 abstract 1
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013-020909 | 2013-02-05 | ||
| JP2013020909 | 2013-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014102948A true RU2014102948A (ru) | 2015-08-10 |
Family
ID=50028739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014102948/15A RU2014102948A (ru) | 2013-02-05 | 2014-01-29 | Вакцинная композиция для мукозального введения |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20140220079A1 (enExample) |
| EP (1) | EP2762161A1 (enExample) |
| JP (1) | JP2014169283A (enExample) |
| KR (1) | KR20140100418A (enExample) |
| CN (1) | CN103961700A (enExample) |
| CA (1) | CA2840978A1 (enExample) |
| IN (1) | IN2014CH00386A (enExample) |
| RU (1) | RU2014102948A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10092642B2 (en) | 2013-10-03 | 2018-10-09 | Nitto Denko Corporation | Mucosal vaccine composition |
| JP6494233B2 (ja) | 2013-10-03 | 2019-04-03 | 日東電工株式会社 | 粘膜ワクチン組成物 |
| WO2016130616A1 (en) | 2015-02-11 | 2016-08-18 | The Johns Hopkins University | Bacteria over-expressing c-di-amp and therapeutic methods |
| US20210106680A1 (en) * | 2018-03-27 | 2021-04-15 | The University Of Tokyo | Adjuvant and vaccine containing adjuvant |
| WO2020189752A1 (ja) * | 2019-03-19 | 2020-09-24 | 日東電工株式会社 | 口腔内粘膜付着型ワクチン製剤 |
| CN111840542B (zh) * | 2020-08-06 | 2023-09-01 | 安徽省力瑞投资管理有限公司 | 被覆磷脂双分子层、单磷脂a及环二核苷酸的铝纳米粒疫苗佐剂-传递系统及其制备方法 |
| US20250127889A1 (en) * | 2021-12-02 | 2025-04-24 | Reiko SHINKURA | Immunostimulatory composition |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL105325A (en) | 1992-04-16 | 1996-11-14 | Minnesota Mining & Mfg | Immunogen/vaccine adjuvant composition |
| US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| US6764840B2 (en) | 1997-05-08 | 2004-07-20 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
| US20050215501A1 (en) * | 2003-10-24 | 2005-09-29 | Coley Pharmaceutical Group, Inc. | Methods and products for enhancing epitope spreading |
| WO2005089777A1 (en) | 2004-03-15 | 2005-09-29 | Karaolis David K R | A method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis |
| DE102004049223A1 (de) | 2004-10-08 | 2006-04-20 | Johannes-Gutenberg-Universität Mainz | Zubereitung zum Impfen, Impfverfahren und Verwendung einer Impf-Zubereitung |
| US20080112974A1 (en) | 2006-09-08 | 2008-05-15 | Duotol Ab | Method for inducing mucosal humoral and cell-mediated immune responses by sublingual administration of antigens |
| EP2162149B1 (en) * | 2007-06-01 | 2013-11-06 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Vaccine for the prevention of breast cancer relapse |
| US9764012B2 (en) * | 2009-04-01 | 2017-09-19 | University Of Miami | Vaccine compositions and methods of use thereof |
| WO2011026111A1 (en) * | 2009-08-31 | 2011-03-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Oral delivery of a vaccine to the large intestine to induce mucosal immunity |
-
2014
- 2014-01-29 CN CN201410043599.7A patent/CN103961700A/zh active Pending
- 2014-01-29 US US14/166,973 patent/US20140220079A1/en not_active Abandoned
- 2014-01-29 IN IN386CH2014 patent/IN2014CH00386A/en unknown
- 2014-01-29 EP EP14000326.0A patent/EP2762161A1/en not_active Withdrawn
- 2014-01-29 JP JP2014014814A patent/JP2014169283A/ja active Pending
- 2014-01-29 KR KR1020140011631A patent/KR20140100418A/ko not_active Withdrawn
- 2014-01-29 RU RU2014102948/15A patent/RU2014102948A/ru not_active Application Discontinuation
- 2014-01-29 CA CA2840978A patent/CA2840978A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014169283A (ja) | 2014-09-18 |
| CA2840978A1 (en) | 2014-08-05 |
| US20140220079A1 (en) | 2014-08-07 |
| EP2762161A1 (en) | 2014-08-06 |
| KR20140100418A (ko) | 2014-08-14 |
| CN103961700A (zh) | 2014-08-06 |
| IN2014CH00386A (enExample) | 2015-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014102946A (ru) | Вакцинная композиция против злокачественной опухоли на основе пептида wt1 для мукозального введения | |
| RU2014102940A (ru) | Композиция противораковой вакцины, содержащая пептид wt1, для трансдермального введения | |
| EA201992327A1 (ru) | Пептид, активирующий рецептор гип | |
| CL2019001077A1 (es) | Derivados de 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f] isoquinolina útiles en el tratamiento del cáncer. | |
| CL2016002148A1 (es) | Derivados de fenilen-1,5-diamina 2,4-disustituidos y aplicaciones de los mismos, y composiciones farmacéuticas y composiciones farmacéuticamente aceptables preparadas a partir de los mismos. | |
| EA201501122A8 (ru) | Новые агонисты соматостатиновых рецепторов подтипа 4 (sstr4) | |
| EA201790525A1 (ru) | Применение агента, активирующего рецептор гамк, для получения седативного и анестезирующего лекарственного средства | |
| RU2014102944A (ru) | Композиция вакцины для трансдермального или трансмукозального введения | |
| AR111314A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| CO2017000222A2 (es) | Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble | |
| EA201700504A1 (ru) | 5-ароматическое алкинилзамещенное бензомидное соединение и способ его получения, фармацевтическая композиция и их применение | |
| EA201690888A1 (ru) | Новые гетероциклические соединения | |
| CY1124251T1 (el) | Παραγωγα καρβοξαμιδιου | |
| EA201400067A1 (ru) | Новая терапевтическая композиция, содержащая апоморфин в качестве активного ингредиента | |
| BR112018007181A2 (pt) | antagonistas de nr2b seletivos | |
| AR107878A1 (es) | Derivado de morfolina | |
| MX2020001531A (es) | Nuevos compuestos hetorociclicos como inhibidores de cdk8/19. | |
| UY36123A (es) | Derivados de carboxamida | |
| MX2021015827A (es) | Antagonista de neurokinin -1. | |
| EA201490031A1 (ru) | Циклоалкил-конденсированные тетрагидрохинолины в качестве модуляторов рецепторов crth | |
| UA109942C2 (ru) | Производные 2-амино-3-(имидазол-2-ил)-пиридин-4-она и их применение как ингибиторов киназы рецептора vegf | |
| EA201390488A1 (ru) | Новые агонисты gpr 119 | |
| PE20190382A1 (es) | Derivados etinilo | |
| EA200901188A1 (ru) | Органолептически приемлемые дозированные лекарственные формы индольных агонистов серотониновых рецепторов для перорального применения и способы их применения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180615 |